FDA Law Blog Turns One! What a Year It Has Been! Thank You!

One year ago today, Hyman, Phelps & McNamara, P.C., started FDA Law Blog with this post and a promise to provide you with timely updates on FDA enforcement actions, proposed rules, personnel changes, new and improved policies, along with related issues such as healthcare fraud and abuse, drug and device reimbursement, and other topics of interest.  Since then, we have made over 200 posts covering hundreds of pages of text and analysis that you are unlikely to find anywhere else (at least not for free!).  The response to FDA Law Blog has been tremendous (as our soaring subscription rates show us).  Over the past year, we have been cited in numerous trade press publications, including (just to name a few) The Pink Sheet, FDA Week, Dickinson’s FDA Review, and FDA News. The pharma blogosphere has also come to rely on FDA Law Blog’s timely information and analysis.  We have been cited (again, just to name a few) by The Wall Street Journal Health Blog, Pharmalot, On Pharma (which called our blog “required reading”), Patent Baristas, Drug and Device Law Blog, and our blogfather, Orange Book Blog, which is run by attorney Aaron Barkoff. 

Of course, none of FDA Law Blog’s success would have been possible without the tremendous support from our Hyman, Phelps & McNamara, P.C. colleagues, who often draft blog posts, and from our avid readers from around the world.  Jeff Wasserstein and I (Kurt Karst), as co-authors of the blog, thank all of you for making FDA Law Blog a success. As we at Hyman, Phelps & McNamara, P.C., know all too well, drafting blog posts is a time-consuming and often difficult task.  There is always a lot going on in our world, and it is a complicated field of law.  We strive to provide you with posts that are long enough to cover the topic, but short enough to be interesting. 

We appreciate the constant feedback we receive from FDA Law Blog readers.  While we do not always post comments, we do read all of them.  Thank you – and keep the comments coming (especially the positive ones)!  We look forward to another year, which appears to hold the possibility of tremendous change for our niche area of the law.